Company Search:
Advanced Search
Sponsored Links
Eczacibasi Ilac Sanayi ve T.A.S. Company Snapshot
Eczacibasi Ilac Sanayi ve T.A.S. operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eczacibasi Ilac Sanayi ve T.A.S. with three other pharmaceutical manufacturers in Europe: Horizon Discovery Group PLC of the United Kingdom (2017 sales of £36.51 million [US$45.87 million] of which 62% was Products), Moberg Pharma AB (publ) of Sweden (439.03 million Swedish Kronor [US$48.27 million] of which 35% was Kerasal Nail /Nalox), and Valneva SE which is based in France (105.29 million Euro [US$119.51 million] of which 88% was Commercialized Vaccines).

Sales Analysis. Eczacibasi Ilac Sanayi ve T.A.S. reported sales of 597.91 million Turkish Liras (US$112.29 million) for the year ending December of 2017. This represents a sharp decrease of 57.7% versus 2016, when the company's sales were 1.41 billion Turkish Liras. Contributing to the drop in overall sales was the 90.0% decline in Personal Care, from 1.05 billion Turkish Liras to 104.62 million Turkish Liras. . However, these declines were partially offset by the increase in sales of Health (up 12.0% to 427.50 million Turkish Liras) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eczacibasi Ilac Sanayi ve T.A.S.
  Stock Performance Chart for Eczacibasi Ilac Sanayi ve T.A.S.
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 2.96
(Figures in Turkish Liras)
1 Week -2.0%   13 Weeks 1.0%  
4 Weeks -21.1%   52 Weeks -30.8%  
Eczacibasi Ilac Sanayi ve T.A.S. Key Data:
  Ticker: ECILC Country: Turkey
  Exchanges: IST Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 597,909,000
(Year Ending Jan 2018).
Employees: 477
  Currency: Turkish Liras Market Cap: 2,028,369,600
  Fiscal Yr Ends: December Shares Outstanding: 685,260,000
  Share Type: Common Closely Held Shares: 550,140,044
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.